SCHEMBL5477798

SCHEMBL5477798

COc1ccc(-c2ccccc2Oc2ccccc2)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ PTGS2 P35354 1/20 0.53
▸ BRD4 O60885 4/20 0.50
▸ TTR P02766 3/20 0.50
▸ KDM4E B2RXH2 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ NPC1 O15118 2/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ PTPRC P08575 1/20 0.47
▸ PTPN1 P18031 1/20 0.47
▸ NCOA1 Q15788 1/20 0.47
▸ NCOA3 Q9Y6Q9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5478760 0.86 PTPRC (0.61) ALDH1A1L3MBTL1KDM4EHSD17B10NPC1
SCHEMBL30452106 0.82 KDM4E (0.57) ALDH1A1MAPK1HTTL3MBTL1KDM4E
SCHEMBL791852 0.78 HTT (0.86) ALDH1A1MAPK1HTTL3MBTL1TTR
SCHEMBL7447151 0.77 NCOA1 (0.59) ALDH1A1MAPK1HTTL3MBTL1PTGS2
SCHEMBL10711068 0.76 NCOA1 (0.69) ALDH1A1MAPK1HTTL3MBTL1PTGS2
SCHEMBL1958156 0.76 NCOA1 (0.74) MAPK1PTGS2BRD4RAB9ATSHR
SCHEMBL20311734 0.75 PTPRC (0.50) ALDH1A1L3MBTL1KDM4EHSD17B10NPC1
SCHEMBL3893284 0.75 NCOA1 (0.58) FYNPTGS2BRD4TSHRNCOA1
SCHEMBL5465021 0.75 KIT (0.60) ALDH1A1L3MBTL1KDM4EHSD17B10NPC1
SCHEMBL7038165 0.75 L3MBTL1 (0.55) FYNALDH1A1MAPK1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K6 FYN 823/4885ALDH1A1 3084/4885MAPK1 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback